Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture of an AAV9-based inv ...

Results from the investigational, randomized ... On November 14, 2024, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...

SHELTON, CT / / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to ...

First, eligible companies must hold or intend to apply for a Good Manufacturing Practice (GMP) Human Medicines license or an Investigational Medicinal Products Directive (IMPD) license.

IND application refers to "Investigational New Drug" application ... CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency's (EMA) committee ...

References: [i] European Commission, Volume 4, EU Guidelines to Good Manufacturing Practice, Medicinal Products for Human and Veterinary Use, Annex 13: Manufacture of Investigational ...